Ovarian tissue cryopreservation and transplantation in patients with cancer
- Authors
- Kim, S.; Lee, Y.; Lee, S.; Kim, T.
- Issue Date
- 2018
- Publisher
- Korean Society of Obstetrics and Gynecology
- Keywords
- Fertility preservation; Neoplasms; Ovarian tissue cryopreservation; Ovarian tissue transplantation; Therapeutics
- Citation
- Obstetrics and Gynecology Science, v.61, no.4, pp.431 - 442
- Indexed
- SCOPUS
KCI
- Journal Title
- Obstetrics and Gynecology Science
- Volume
- 61
- Number
- 4
- Start Page
- 431
- End Page
- 442
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/131821
- DOI
- 10.5468/ogs.2018.61.4.431
- ISSN
- 2287-8572
- Abstract
- Chemotherapy and radiotherapy improved survival rates of patients with cancer. However, they can cause ovarian failure and infertility in women of reproductive age. Infertility following cancer treatment is considered a major quality of life issue. Ovarian tissue cryopreservation and transplantation is an important option for fertility preservation in adult patients with cancer who need immediate chemotherapy or do not want to undergo ovarian stimulation. Ovarian tissue freezing is the only option for preserving the fertility of prepubertal patients with cancer. In a recent review, it was reported that frozen-thawed ovarian transplantation has lead to about 90 live births and the conception rate was about 30%. Endocrine function recovery was observed in 92.9% between 3.5 and 6.5 months after transplantation. Based on our review, ovarian tissue cryopreservation and transplantation may be carefully considered before cancer treatment in order to preserve fertility and endocrine function in young cancer survivors. © 2018 Korean Society of Obstetrics and Gynecology.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.